HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Maggi Selected Research

Erectile Dysfunction

1/2022Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status.
12/2021Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome.
6/2021Male Sexual Dysfunctions in the Infertile Couple-Recommendations From the European Society of Sexual Medicine (ESSM).
1/2021Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial.
12/2020Family History for Cardio-Metabolic Diseases: A Predictor of Major Adverse Cardiovascular Events in Men With Erectile Dysfunction.
2/2020Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study.
7/2019Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial.
6/2019Impact of Metabolically Healthy Obesity in Patients with Andrological Problems.
1/2019Testosterone Replacement Therapy for Sexual Symptoms.
12/2017Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Maggi Research Topics

Disease

75Hypogonadism (Hypergonadotropic Hypogonadism)
12/2021 - 11/2002
53Erectile Dysfunction
01/2022 - 12/2005
33Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 09/2006
25Inflammation (Inflammations)
01/2022 - 02/2007
24Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2020 - 01/2006
23Lower Urinary Tract Symptoms
12/2021 - 02/2007
17Obesity
10/2022 - 10/2008
17Prostatic Neoplasms (Prostate Cancer)
07/2021 - 01/2002
13Neoplasms (Cancer)
10/2022 - 01/2002
10Fibrosis (Cirrhosis)
07/2020 - 01/2012
8Hypertension (High Blood Pressure)
10/2022 - 01/2009
8Type 2 Diabetes Mellitus (MODY)
10/2022 - 11/2008
8Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 07/2007
8Hypoxia (Hypoxemia)
01/2017 - 05/2006
7Chronic Disease (Chronic Diseases)
05/2020 - 04/2010
7Prostatitis
06/2019 - 02/2007
7Insulin Resistance
01/2018 - 01/2012
6Weight Loss (Weight Reduction)
10/2022 - 01/2012
6Hyperglycemia
12/2015 - 01/2009
5Ejaculatory Dysfunction
06/2021 - 12/2005
5Hyponatremia
05/2021 - 01/2013
5Hypersensitivity (Allergy)
05/2014 - 05/2006
4Cognitive Dysfunction
10/2022 - 07/2007
4Infections
01/2022 - 11/2013
4Overactive Urinary Bladder (Overactive Bladder)
12/2021 - 05/2008
4Alcoholism (Alcohol Abuse)
05/2021 - 08/2010
4Abdominal Obesity
04/2015 - 08/2011
3COVID-19
05/2021 - 01/2021
3Feeding and Eating Disorders (Eating Disorder)
01/2021 - 01/2012
3Morbid Obesity
07/2019 - 06/2013
3Male Infertility (Male Sterility)
06/2019 - 05/2006
3Diabetes Mellitus
01/2018 - 06/2012
3Hyperprolactinemia
04/2015 - 09/2007
3Dyslipidemias (Dyslipidemia)
06/2013 - 01/2010
3Atherosclerosis
10/2011 - 04/2010
2Paraganglioma (Paragangliomas)
01/2022 - 10/2020
2Pheochromocytoma
01/2022 - 10/2020
2Sarcopenia
12/2021 - 06/2016
2Frailty
12/2021 - 01/2021
2Adrenocortical Carcinoma
10/2021 - 10/2020
2Pneumonia (Pneumonitis)
05/2021 - 01/2021
2Wounds and Injuries (Trauma)
01/2021 - 10/2003
2Bulimia (Binge Eating)
01/2021 - 01/2020
2Vomiting
01/2021 - 01/2020
2Non-alcoholic Fatty Liver Disease
01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

94Testosterone (Sustanon)FDA Link
10/2022 - 05/2004
26AndrogensIBA
12/2021 - 01/2002
17Tadalafil (Cialis)FDA Link
12/2021 - 05/2006
17Phosphodiesterase 5 InhibitorsIBA
02/2020 - 03/2007
15omega-Chloroacetophenone (Mace)IBA
12/2020 - 04/2010
12Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2007
12GonadotropinsIBA
01/2021 - 09/2006
9Hormones (Hormone)IBA
07/2021 - 10/2008
9Messenger RNA (mRNA)IBA
01/2020 - 02/2002
9Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2019 - 11/2002
9Vardenafil Dihydrochloride (Levitra)FDA Link
01/2014 - 03/2007
8Glucose (Dextrose)FDA LinkGeneric
05/2021 - 01/2011
8Sildenafil Citrate (Viagra)FDA Link
07/2020 - 05/2004
8Androgen Receptors (Androgen Receptor)IBA
02/2015 - 04/2006
8Interleukin-8 (Interleukin 8)IBA
11/2013 - 02/2007
7CytokinesIBA
01/2022 - 02/2007
7BXL628IBA
04/2009 - 02/2005
6Insulin (Novolin)FDA Link
10/2022 - 08/2011
6SteroidsIBA
01/2022 - 11/2002
6Gonadal Steroid Hormones (Sex Hormones)IBA
01/2018 - 10/2008
6Interleukin-6 (Interleukin 6)IBA
01/2017 - 04/2009
6obeticholic acidIBA
01/2017 - 01/2011
6Estrogens (Estrogen)FDA Link
12/2016 - 02/2004
6Estradiol (Delestrogen)FDA LinkGeneric
06/2013 - 04/2004
6rho-Associated KinasesIBA
10/2011 - 02/2007
5Tamsulosin (Flomax)FDA LinkGeneric
12/2021 - 06/2012
5ElectrolytesIBA
05/2021 - 01/2013
5Triglycerides (Triacylglycerol)IBA
05/2021 - 08/2010
5Prostate-Specific Antigen (Semenogelase)IBA
04/2020 - 01/2010
5ProlactinIBA
12/2015 - 09/2007
5Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
03/2013 - 03/2006
4SodiumIBA
11/2021 - 01/2015
4Acetylcholine (Acetylcholine Chloride)FDA Link
07/2021 - 03/2006
4Pharmaceutical PreparationsIBA
01/2021 - 10/2003
4Proteins (Proteins, Gene)FDA Link
10/2020 - 05/2004
4Luteinizing Hormone (Lutropin)FDA LinkGeneric
01/2016 - 05/2009
4Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2014 - 03/2007
4Y 27632IBA
05/2014 - 05/2007
4Calcitriol Receptors (Calcitriol Receptor)IBA
04/2010 - 02/2007
3Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022 - 01/2012
3Neuroprotective AgentsIBA
02/2021 - 01/2019
3LipidsIBA
01/2018 - 08/2011
3Biological ProductsIBA
01/2018 - 01/2006
3CholesterolIBA
02/2015 - 10/2003
3Cholecalciferol (Vitamin D3)FDA Link
09/2006 - 01/2002
3Vitamin DFDA LinkGeneric
09/2006 - 04/2006
3Triptorelin Pamoate (Trelstar)FDA Link
08/2005 - 11/2002
2LDL CholesterolIBA
04/2022 - 09/2014
2Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2022 - 10/2020
2C-Reactive ProteinIBA
01/2022 - 12/2021

Therapy/Procedure

44Therapeutics
12/2021 - 01/2002
7Prostatectomy (Retropubic Prostatectomy)
02/2020 - 05/2009
3Aftercare (After-Treatment)
12/2021 - 01/2002
3Bariatric Surgery
01/2018 - 06/2013
3Drug Therapy (Chemotherapy)
01/2016 - 02/2015